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Formative Care:  Rethinking the medicine of frailty.  1 
    2 
Abstract 3 
The care and support of the increasing ill, frail and dependent population, is poorly 4 
served by orthodox health and social care. Policy initiatives such as the integration of 5 
the funding of health and care services, admission avoidance schemes and 6 
improved end of life care are generally reactive to a service problem as opposed to 7 
patient need.  What has been lacking generally has been an understanding of the 8 
dependent population and the potential for developing a positive proactive approach 9 
to wellbeing and life quality in lives reframed by frailty and dependency.  10 
It is proposed that the term “Formative care”, would bring distinction from traditional 11 
health and care strategies of prevention, diagnosis, treatment, rehabilitation, 12 
palliative and end of life care.  13 
The use of life trajectories of older people can help define the population of the frail 14 
for whom new formative approaches to health may be effective and in the absence 15 
of clear clinical markers that define the limits of traditional medical approaches, the 16 
watersheds of social transitions may provide a prompt for the institution of a 17 
formative approach to health and care.  18 
Recognising the health and care space for a formative approach to health and care 19 
may facilitate a coherent approach to the development of understanding, policy and 20 
practise and will necessitate new research to inform best practise.  21 
 22 
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 25 
Introduction 26 
Modern Medicine generally can be described in terms of prevention, diagnosis and 27 
the evidenced treatment of acute and long term conditions. Additionally and 28 
particularly for older people needs assessment, rehabilitation and good end of life 29 
care are well established. These clinical domains are broadly mirrored in social care 30 
where prevention, personalisation, enablement, empowerment and risk management 31 
are commonly cited.  32 
The early days of Geriatric Medicine highlighted the importance of assessment, 33 
treatment and rehabilitation for reducing dependence on care (1) as has the 34 
improvement of living conditions and general support (2). Collectively, these have 35 
successfully limited avoidable dependency. However, ageing populations feature a 36 
growing number of older dependent people who are increasingly unresponsive to 37 
traditional treatment(s) but for whom dying and death is not imminently anticipated. 38 
This emerging population of the frail old is increasingly becoming recognised (3) as 39 
is the complexity of managing multiple morbidities (4). However, there is little 40 
coherence to the purpose of medicine for this population in spite of frequent public, 41 
professional and political concerns with common themes of dignity and needs, 42 
quality of life and affordability(5).  43 
The continued use of the denominator of age without qualification by clinical and 44 
socio-economic circumstances creates uncertainty for policy makers, should they 45 
plan for a healthy ageing population, a dependent one or a mix and if so what 46 
proportion? Persisting difficulties in achieving a sustainable funding solution for long 47 
term care may be in part rooted in mixed demographic/epidemiological messages 48 
and uncertainties of what is required now and in the future for an increasingly aged 49 
society.  50 
   51 
Life trajectories to death and medical responses  52 
It is widely recognised that multiple morbidities increasingly complicate health and 53 
the specialist treatment of multiple diseases in specialist silos is increasingly 54 
questioned (4). The analysis by Lynn and Anderson (6) of the trajectories of a large 55 
group of US Medicare (an older population) beneficiaries tracked towards their death 56 
provides a compelling classification of the clinical pathway to death of an ageing 57 
population. Four broad categories were identified, 58 
 20 per cent of deaths followed an illness such as cancer that is characterised 59 
by a clear clinical transition from living with to dying from a condition that has 60 
an unrelenting progression. In the UK this group will be recognised as having 61 
benefited from the development and increasing availability of palliative and 62 
hospice care. 63 
 20 per cent of deaths were related to progressive long-term conditions 64 
complicated by acute exacerbations during which an increasing likelihood of 65 
death is recognised, for example Chronic Obstructive Pulmonary Disease. 66 
People in this category are likely to be in programmes of chronic disease 67 
management where the limits of treatment and likelihood of dying and its 68 
nature are understood by specialists, primary care and crucially by patients 69 
and their families, enabling their care and support needs to be informed by 70 
this condition.  71 
 20 per cent of deaths were classified as “sudden”, for example a fatal 72 
myocardial infarction or an accident. For this group preventative medicine and 73 
continued developments in safety may yield further reductions.   74 
 The largest group of 40% were poignantly described as dying after a period of 75 
“progressive dwindling”.  This group are typified by people with conditions 76 
such as Alzheimer’s disease and other degenerative conditions that are 77 
individually or collectively progressively disabling.  It is this population that 78 
forms the greatest collective demand of health and care support over long 79 
periods and the population that is the prime concern of this paper.  80 
 81 
The growing importance of progressive frailty  82 
As progress continues to be made in the treatment of diseases that have previously 83 
dominated mortality in later life the importance of conditions individually and 84 
collectively that lead to dependence and frailty will grow both proportionally and 85 
absolutely. 86 
For life trajectories such as cancer or chronic progressive conditions clinical 87 
watersheds are often identified for example, the disease progression that triggers a 88 
clear change in the rationale and expectations of treatment and care exemplified by 89 
cancer that becomes unresponsive to treatment creating a “watershed” to palliative 90 
care and end of life care. The clarity of this “watershed” approach has transformed 91 
care at the end of life in Cancer but it has been extended, somewhat uncritically, to 92 
the progressively frail. Very frail patients may have a life expectancy of several years 93 
and are certainly not “actively” dying.  94 
 95 
Traditional health, care and frailty  96 
Evidence based medicine is generally based on “intention to treat” trials where 97 
outcome benefits are sufficient to justify the risks of treatment and costs. Evidence 98 
for sustained treatment of conditions over long periods often into great age often rest 99 
on an extrapolation of evidence which may be tenuous in advanced frailty often 100 
complicated by co-morbidities. Furthermore, the responsiveness of many diseases to 101 
treatment often diminishes with disease progression and proven benefits may 102 
increasingly become blurred or outweighed by adverse effects. The unacceptability 103 
of excluding older people from research is becoming increasingly recognised (7).  104 
Often discharge notes from hospital of frail patients, particularly when transferred to 105 
care homes infer that, “nothing more can/could or should be done”, yet patients 106 
typically will be on an extensive list of treatments and subject to varying degrees of 107 
planning for the end of life. This is a bleak and confusing approach and the 108 
uncertainty it creates may contribute both to the application of care pathways for end 109 
of life care when the diagnosis of dying is uncertain (8) and the right to determine 110 
death debate. The majority of these frail patients are entering an emerging “medical 111 
space” where the medical purpose needs both clarification and communication. The 112 
expression “enabling the best possible life quality and experience in the context of a 113 
life reframed by frailty” captures the essence of what many practitioners intuitively 114 
think and often practise. Calling this a “Formative” approach to medical care may 115 
help distinguish it from palliative and end of life care and the more established 116 
diagnosis and treatment of modern medicine.   117 
 118 
Social watersheds and formative medical care 119 
Progressive frailty seldom exhibits a clear clinical watershed although one may be 120 
identified in retrospect. However, progressive frailty is often accompanied by social 121 
watersheds of which admission to a care home for long-term care is perhaps the 122 
most readily identifiable.  Care Home admission usually follows assessment(s) that 123 
centre on eligibility and the seeking of opportunities through treatment and 124 
rehabilitation to avert admission rather than the on-going health care. An individual 125 
with dementia may require the sanctuary and support of a care home for an average 126 
length of stay of some 20 months. Whilst the importance of good end of life care is 127 
acknowledged, active dying will only occupy a small percentage of that stay, so for 128 
the greater part of residence a clinical approach that seeks to optimise quality of life 129 
seems obvious but poorly stated. If Care Home admission were to be established as 130 
a an initial trigger for the “Formative” approach increasing knowledge could develop 131 
understanding of when a transition to a formative approach may be appropriate more 132 
widely in the community.  133 
The following case vignettes illustrate a “Formative” approach to medical care 134 
following admission to a care home, 135 
 The person with dementia has been treated with sedation in the community to 136 
enable family carers to cope with disordered sleep pattern. A combination of 137 
carer exhaustion and disease progression in spite of maximal support 138 
necessitates care home admission. Sedation is withdrawn and whilst sleep 139 
patterns remain considerably disturbed the twenty four hour care can 140 
accommodate this and the person’s behavioural pattern improves such that 141 
day trips with family become possible. The individual remains dependent on 142 
care but their life quality becomes much improved.                                   143 
Note: 75% of prescriptions for antipsychotic medication of care home 144 
residents are initiated prior to admission to the care home (Personal 145 
communication Pharmacy Plus December 2011) 146 
 The person with increasingly poor mobility related to long standing 147 
Parkinsonism whose treatment has been escalated in an attempt to maintain 148 
mobility sufficient for family to support at home develops a treatment related 149 
psychosis and is admitted to a care home. With 24 hour access to 2 carer 150 
enabled transfers treatment is reduced, whilst physically dependent lucidity is 151 
regained to enable meaningful socialisation. Note: overall 5% of care home 152 
residents are diagnosed with Parkinsonism (9)  153 
 The malnourished person with advancing frailty, mild confusion and repeated 154 
falls is admitted on long term treatment with beta blockers for hypertension 155 
and Statins for cardiac risk and dietary supplements. The patient exhibits 156 
postural hypotension and so the beta blockers are discontinued as are the 157 
Statins and supplemental feeds. Meal times are supervised and the patient 158 
gains weight and strength to the extent that after several months they are 159 
discharged home lucid and independent with no on-going support. It is 160 
unclear whether the improvement of mental state has been due to improved 161 
cerebral perfusion or a beta blocker related pseudo-dementia.  162 
The clinical interventions described are distinct active interventional approaches that 163 
are not easily classifiable in common approaches to medical practise, though 164 
experienced Geriatricians and General Practitioners will recognise them. They all 165 
illustrate an active approach that seeks the “best deal” for the patient in the context 166 
of their circumstances and are about optimising well-being and whilst evidence of 167 
inappropriate prescribing is recorded (10) guidance on positive drug withdrawal is 168 
lacking (11). The altered nature of therapeutics in frailty is starting to be recognised 169 
as a dark corner of medicine with calls for trials to clarify the effective and ineffective 170 
use of medicines in older people (12). There is evidence to support systematic 171 
discontinuation of medication in older people who present for geriatric assessment 172 
within the community (13) but such work needs to be undertaken on a larger scale 173 
before robust guidance can be constructed. 174 
Making formative care evidence based 175 
Developing a practice of Formative care for the frail will require systematic 176 
programmes of research into the withdrawal of treatment and the benefits of various 177 
interventions, to develop guidelines. Such trials are unlikely to be funded by 178 
Pharmaceutical companies but as electronic records of prescribing and care become 179 
more accessible and both the relative ease of access to care home residents many 180 
traditional difficulties may be overcome. Furthermore, new treatments targeting 181 
conditions such as established and advanced Alzheimer’s data from assessments 182 
could, at scale, provide not only disease registries but a means to investigate new 183 
interventions against a contemporary database. 184 
This approach focuses initially on care home residents it is important to recognise 185 
that in the UK the number of care home beds exceed all NHS beds by more than 186 
three times and that some 80% of the adult social care budget is currently committed 187 
to the funding of care home places care homes.  Whilst prevention, re-ablement 188 
together with good palliative and end of life care remain crucial an evidenced 189 
“Formative” approach proposed will reduce futile and expensive medical treatments 190 
as well as promote well being and maintain outcomes as proactive managed care 191 
approach has already been proven to deliver (16). Substantial savings will accrue 192 
from the reduction of ineffective prescribed drugs. With over 400000 residents in 193 
care homes presently prescribed an average of 7 items potential savings of £100 194 
million annually to the drug bill and considerable reductions in acute hospitalisations 195 
as a result of iatrogenic disease projected. 196 
  197 
Conclusion  198 
The lack of systematic approach to the health and care of the frail is a contemporary 199 
demonstration of the inverse care law (17). The use of a social watershed as a 200 
trigger for a developed “Formative” approach the medical care of people resident in a 201 
care home promises a rare combination of improved patient well being, a positive 202 
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